XML 79 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details 2) (USD $)
12 Months Ended
Oct. 27, 2013
Oct. 28, 2012
Oct. 30, 2011
Stock-based compensation expense, along with the related income tax benefit      
Stock based compensation expense recognized $ 17,596,000 $ 16,710,000 $ 17,229,000
Income tax benefit recognized (6,655,000) (6,334,000) (6,542,000)
After-tax stock-based compensation expense 10,941,000 10,376,000 10,687,000
Stock-based compensation expense unrecognized 7,400,000    
Period for recognition of unrecognized stock-based compensation expense 4 years 4 months 24 days    
Number of shares available for future grants 27,900,000 30,000,000 32,600,000
Stock options
     
Stock-based compensation      
Cash received from stock options exercised 30,200,000 14,700,000 53,800,000
Tax benefit realized from stock options, aggregate 29,400,000 11,400,000 20,800,000
Reconciliation of Stock Options      
Outstanding, at the beginning of the period (in shares) 20,454,000    
Granted (in shares) 2,218,000    
Exercised (in shares) 4,181,000    
Forfeited (in shares) 25,000    
Outstanding, at the end of the period (in shares) 18,466,000 20,454,000  
Exercisable at the end of the period (in shares) 12,429,000    
Weighted Average Exercise Price      
Outstanding at the beginning of the period (in dollars per share) $ 19.67    
Granted (in dollars per share) $ 32.19    
Exercised (in dollars per share) $ 15.56    
Forfeited (in dollars per share) $ 27.77    
Outstanding at the end of the period (in dollars per share) $ 22.09 $ 19.67  
Exercisable at end of period (in dollars per share) $ 19.02    
Weighted Average Remaining Contractual Term      
Outstanding at the end of the period 5 years 7 months 6 days    
Exercisable at end of period 4 years 3 months 18 days    
Aggregate Intrinsic Value      
Outstanding at the end of the period 397,571,000    
Exercisable at end of period 305,727,000    
Weighted-average grant date fair value of stock options granted, and the total intrinsic value of options exercised      
Weighted-average grant date fair value (in dollars per share) $ 5.50 $ 5.64 $ 5.54
Intrinsic value of exercised options 77,610,000 30,210,000 54,859,000
Weighted-average assumptions used to calculate fair value of each ordinary option award      
Risk free interest rate (as a percent) 1.40% 1.80% 2.90%
Dividend yield (as a percent) 2.10% 2.00% 2.00%
Stock price volatility (as a percent) 20.00% 21.00% 21.00%
Expected option life 8 years 8 years 8 years
Nonvested shares
     
Reconciliation of the nonvested shares      
Nonvested shares at the beginning of the period 139,000    
Nonvested shares granted in period 45,000    
Nonvested shares vested in period 72,000    
Nonvested shares at the end of the period 112,000 139,000  
Weighted-average grant date fair value and total fair value of nonvested shares granted, vested and forfeited      
Nonvested shares at the beginning of the period (in dollars per share) $ 21.47    
Nonvested shares granted in period (in dollars per share) $ 35.42 $ 28.98 $ 25.11
Nonvested shares vested in period (in dollars per share) $ 25.07    
Nonvested shares at the end of the period (in dollars per share) $ 24.77 $ 21.47  
Fair value of nonvested shares granted 1,600,000 1,369,000 1,299,000
Fair value of shares vested $ 1,824,000 $ 2,476,000 $ 751,000